Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -122.15% is 18% below its 5-year average of -103.77%, near the high end of its 5-year range (-814.43%–-66.66%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.38% below its 12-month average of -94.41%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -122.15%.
RETURN ON INVESTED CAPITAL (ROIC)
-122.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-94.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-93.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-103.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-29.38%
CURRENT VS 3Y AVG
-30.80%
CURRENT VS 5Y AVG
-17.72%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-242.70%
vs the sector median at left
Lucyd, Inc
Market Cap
$5.83M
Return on Invested Capital (ROIC)
-122.15%
TTM Avg
-94.41%
3Y Avg
-93.39%
5Y Avg
-103.77%
Market Cap
$5.82M
Return on Invested Capital (ROIC)
-84.15%
TTM Avg
-84.15%
3Y Avg
-84.15%
5Y Avg
-84.15%
Market Cap
$5.89M
Return on Invested Capital (ROIC)
-10.98%
TTM Avg
-32.05%
3Y Avg
-35.21%
5Y Avg
-35.46%
Market Cap
$5.92M
Return on Invested Capital (ROIC)
-82.84%
TTM Avg
-84.28%
3Y Avg
-109.54%
5Y Avg
-250.89%
Market Cap
$5.73M
Return on Invested Capital (ROIC)
-0.32%
TTM Avg
-32.77%
3Y Avg
-50.72%
5Y Avg
-41.90%
Market Cap
$5.70M
Return on Invested Capital (ROIC)
-80.65%
TTM Avg
-65.64%
3Y Avg
-61.70%
5Y Avg
-66.02%
Market Cap
$5.63M
Return on Invested Capital (ROIC)
-94.08%
TTM Avg
-1223.16%
3Y Avg
-731.00%
5Y Avg
-532.24%
Market Cap
$6.11M
Return on Invested Capital (ROIC)
-15.99%
TTM Avg
-17.35%
3Y Avg
-65.46%
5Y Avg
-66.42%
Market Cap
$6.28M
Return on Invested Capital (ROIC)
-209.05%
TTM Avg
-147.42%
3Y Avg
-107.09%
5Y Avg
-98.13%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lucyd, Inc (LUCY) | $5.83M | -122.15% | -94.41% | -93.39% | -103.77% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.82M | -84.15% | -84.15% | -84.15% | -84.15% |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.89M | -10.98% | -32.05% | -35.21% | -35.46% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.92M | -82.84% | -84.28% | -109.54% | -250.89% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.73M | -0.32% | -32.77% | -50.72% | -41.90% |
| enVVeno Medical Corporation (NVNO)vs › | $5.70M | -80.65% | -65.64% | -61.70% | -66.02% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | -94.08% | -1223.16% | -731.00% | -532.24% |
| Scienture Holdings, Inc. (SCNX)vs › | $6.11M | -15.99% | -17.35% | -65.46% | -66.42% |
| Femasys Inc. (FEMY)vs › | $6.28M | -209.05% | -147.42% | -107.09% | -98.13% |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.35M | -175.26% | -258.55% | -208.94% | -173.09% |
ROIC
-122.2%
ROE
-111.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -122.15% |
| 2026-03-31 | -106.43% |
| 2025-12-31 | -93.41% |
| 2025-09-30 | -79.38% |
| 2025-06-30 | -70.70% |
| 2025-03-31 | -104.26% |
| 2024-12-31 | -87.07% |
| 2024-09-30 | -75.76% |
| 2024-06-30 | -110.34% |
| 2024-03-31 | -190.51% |
| 2023-12-31 | -123.35% |
| 2023-09-30 | -81.15% |
| 2023-06-30 | -66.66% |
| 2023-03-31 | -126.24% |
| 2022-12-31 | -134.34% |
| 2022-09-30 | -88.54% |
| 2022-06-30 | -814.43% |
| 2022-03-31 | -611.97% |
| 2021-12-31 | -645.47% |
| 2021-09-30 | -427.22% |
| 2021-06-30 | -345.81% |
| 2020-12-31 | -999.22% |
